Bis-1-(8-(1-hydroxyethyl)deuteroporphyrin-3-yl)ethyl Ether
Bis-1-(8-(1-hydroxyethyl)deuteroporphyrin-3-yl)ethyl Ether Uses, Dosage, Side Effects, Food Interaction and all others data.
Bis-1-(8-(1-hydroxyethyl)deuteroporphyrin-3-yl)ethyl Ether is under investigation in clinical trial NCT00118222 (High Light and Low Light Dose PDT in Glioma).
Trade Name | Bis-1-(8-(1-hydroxyethyl)deuteroporphyrin-3-yl)ethyl Ether |
Generic | Dihematoporphyrin ether |
Dihematoporphyrin ether Other Names | bis-1-(8-(1-hydroxyethyl)deuteroporphyrin-3-yl)ethyl ether, DHP ether, Dihematoporphyrin ether |
Type | |
Formula | C68H74N8O11 |
Weight | Average: 1179.385 Monoisotopic: 1178.547705235 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
![Bis-1-(8-(1-hydroxyethyl)deuteroporphyrin-3-yl)ethyl Ether Bis-1-(8-(1-hydroxyethyl)deuteroporphyrin-3-yl)ethyl Ether](https://www.medicinesfaq.com/media/png/bis-1-8-1-hydroxyethyldeuteroporphyrin-3-ylethyl-ether.png)
Innovators Monograph
You find simplified version here Bis-1-(8-(1-hydroxyethyl)deuteroporphyrin-3-yl)ethyl Ether